Selected research
Industry Research
Anti-Infectives Industry Research Report 2026
Market perspective
The global Anti-Infectives market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Anti-Infectives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Anti-Infectives is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Anti-Infectives is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Anti-Infectives include Astra Zeneca plc, Glaxo SmithKline plc, Novartis, Wockhardt ltd, Pfizer, Roche, Merck, Johnson & Johnson and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Anti-Infectives market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anti-Infectives Market by Company
Astra Zeneca plc
Glaxo SmithKline plc
Novartis
Wockhardt ltd
Pfizer
Roche
Merck
Johnson & Johnson
Sanofi
Anti-Infectives Segment by Type
Antifungal
Antibacterial
Antiviral
Anti-Infectives Segment by Application
Retail Pharmacies
Mail Order Pharmacies
Hospital Pharmacies
Anti-Infectives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Infectives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Anti-Infectives manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Anti-Infectives by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Anti-Infectives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antifungal
- Antibacterial
- Antiviral
Applications
- Retail Pharmacies
- Mail Order Pharmacies
- Hospital Pharmacies
Companies covered
- Astra Zeneca plc
- Glaxo SmithKline plc
- Novartis
- Wockhardt ltd
- Pfizer
- Roche
- Merck
- Johnson & Johnson
- Sanofi
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Anti-Infectives Market Size (2021-2032)
- 2.2.2 Global Anti-Infectives Sales (2021-2032)
- 2.2.3 Global Anti-Infectives Market Average Price (2021-2032)
- 2.3 Anti-Infectives by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Antifungal
- 2.3.3 Antibacterial
- 2.3.4 Antiviral
- 2.4 Anti-Infectives by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacies
- 2.4.3 Mail Order Pharmacies
- 2.4.4 Hospital Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Anti-Infectives Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Anti-Infectives Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Anti-Infectives Revenue of Manufacturers (2021-2026)
- 3.4 Global Anti-Infectives Average Price by Manufacturers (2021-2026)
- 3.5 Global Anti-Infectives Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Anti-Infectives, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Anti-Infectives, Product Type & Application
- 3.8 Global Manufacturers of Anti-Infectives, Established Date
- 3.9 Global Anti-Infectives Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Astra Zeneca plc
- 4.1.1 Astra Zeneca plc Company Information
- 4.1.2 Astra Zeneca plc Business Overview
- 4.1.3 Astra Zeneca plc Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Astra Zeneca plc Anti-Infectives Product Portfolio
- 4.1.5 Astra Zeneca plc Recent Developments
- 4.2 Glaxo SmithKline plc
- 4.2.1 Glaxo SmithKline plc Company Information
- 4.2.2 Glaxo SmithKline plc Business Overview
- 4.2.3 Glaxo SmithKline plc Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Glaxo SmithKline plc Anti-Infectives Product Portfolio
- 4.2.5 Glaxo SmithKline plc Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Anti-Infectives Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Wockhardt ltd
- 4.4.1 Wockhardt ltd Company Information
- 4.4.2 Wockhardt ltd Business Overview
- 4.4.3 Wockhardt ltd Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Wockhardt ltd Anti-Infectives Product Portfolio
- 4.4.5 Wockhardt ltd Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Anti-Infectives Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 Roche
- 4.6.1 Roche Company Information
- 4.6.2 Roche Business Overview
- 4.6.3 Roche Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Roche Anti-Infectives Product Portfolio
- 4.6.5 Roche Recent Developments
- 4.7 Merck
- 4.7.1 Merck Company Information
- 4.7.2 Merck Business Overview
- 4.7.3 Merck Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merck Anti-Infectives Product Portfolio
- 4.7.5 Merck Recent Developments
- 4.8 Johnson & Johnson
- 4.8.1 Johnson & Johnson Company Information
- 4.8.2 Johnson & Johnson Business Overview
- 4.8.3 Johnson & Johnson Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Johnson & Johnson Anti-Infectives Product Portfolio
- 4.8.5 Johnson & Johnson Recent Developments
- 4.9 Sanofi
- 4.9.1 Sanofi Company Information
- 4.9.2 Sanofi Business Overview
- 4.9.3 Sanofi Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sanofi Anti-Infectives Product Portfolio
- 4.9.5 Sanofi Recent Developments
5 Global Anti-Infectives Market Scenario by Region
- 5.1 Global Anti-Infectives Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Anti-Infectives Sales by Region: 2021-2032
- 5.2.1 Global Anti-Infectives Sales by Region: 2021-2026
- 5.2.2 Global Anti-Infectives Sales by Region: 2027-2032
- 5.3 Global Anti-Infectives Revenue by Region: 2021-2032
- 5.3.1 Global Anti-Infectives Revenue by Region: 2021-2026
- 5.3.2 Global Anti-Infectives Revenue by Region: 2027-2032
- 5.4 North America Anti-Infectives Market Facts & Figures by Country
- 5.4.1 North America Anti-Infectives Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Anti-Infectives Sales by Country (2021-2032)
- 5.4.3 North America Anti-Infectives Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Anti-Infectives Market Facts & Figures by Country
- 5.5.1 Europe Anti-Infectives Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Anti-Infectives Sales by Country (2021-2032)
- 5.5.3 Europe Anti-Infectives Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Anti-Infectives Market Facts & Figures by Country
- 5.6.1 Asia Pacific Anti-Infectives Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Anti-Infectives Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Anti-Infectives Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Anti-Infectives Market Facts & Figures by Country
- 5.7.1 South America Anti-Infectives Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Anti-Infectives Sales by Country (2021-2032)
- 5.7.3 South America Anti-Infectives Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Anti-Infectives Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Anti-Infectives Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Anti-Infectives Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Anti-Infectives Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Anti-Infectives Sales by Type (2021-2032)
- 6.1.1 Global Anti-Infectives Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Anti-Infectives Sales Market Share by Type (2021-2032)
- 6.2 Global Anti-Infectives Revenue by Type (2021-2032)
- 6.2.1 Global Anti-Infectives Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Anti-Infectives Revenue Market Share by Type (2021-2032)
- 6.3 Global Anti-Infectives Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Anti-Infectives Sales by Application (2021-2032)
- 7.1.1 Global Anti-Infectives Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Anti-Infectives Sales Market Share by Application (2021-2032)
- 7.2 Global Anti-Infectives Revenue by Application (2021-2032)
- 7.2.1 Global Anti-Infectives Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Anti-Infectives Revenue Market Share by Application (2021-2032)
- 7.3 Global Anti-Infectives Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Anti-Infectives Value Chain Analysis
- 8.1.1 Anti-Infectives Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Anti-Infectives Production Mode & Process
- 8.2 Anti-Infectives Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Anti-Infectives Distributors
- 8.2.3 Anti-Infectives Customers
9 Global Anti-Infectives Analyzing Market Dynamics
- 9.1 Anti-Infectives Industry Trends
- 9.2 Anti-Infectives Industry Drivers
- 9.3 Anti-Infectives Industry Opportunities and Challenges
- 9.4 Anti-Infectives Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst